BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 248 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $95,000 | +39.7% | 1,500 | +91.6% | 0.01% | +60.0% |
| Q2 2021 | $68,000 | +23.6% | 783 | +30.5% | 0.01% | -16.7% |
| Q3 2020 | $55,000 | -30.4% | 600 | -41.5% | 0.01% | -40.0% |
| Q2 2020 | $79,000 | +426.7% | 1,025 | +282.5% | 0.01% | 0.0% |
| Q1 2020 | $15,000 | -79.2% | 268 | -70.2% | 0.01% | +42.9% |
| Q4 2019 | $72,000 | +100.0% | 900 | +80.0% | 0.01% | +75.0% |
| Q3 2019 | $36,000 | -52.0% | 500 | -37.5% | 0.00% | -50.0% |
| Q2 2019 | $75,000 | +29.3% | 800 | +7.0% | 0.01% | +100.0% |
| Q3 2018 | $58,000 | +93.3% | 748 | +124.0% | 0.00% | +33.3% |
| Q1 2018 | $30,000 | -79.5% | 334 | -82.8% | 0.00% | -78.6% |
| Q4 2017 | $146,000 | +4766.7% | 1,944 | +3500.0% | 0.01% | – |
| Q3 2017 | $3,000 | -89.7% | 54 | -90.7% | 0.00% | -100.0% |
| Q2 2017 | $29,000 | -70.7% | 583 | -76.5% | 0.00% | -70.0% |
| Q1 2017 | $99,000 | -8.3% | 2,482 | -35.6% | 0.01% | -16.7% |
| Q4 2016 | $108,000 | – | 3,854 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 716,539 | $36,192,000 | 12.35% |
| CADIAN CAPITAL MANAGEMENT, LP | 2,020,629 | $102,062,000 | 6.89% |
| Casdin Capital, LLC | 1,150,000 | $58,087,000 | 4.91% |
| DAFNA Capital Management LLC | 261,280 | $13,197,000 | 3.60% |
| Nextech Invest Ltd. | 188,228 | $9,507,000 | 3.21% |
| Eagle Health Investments LP | 170,551 | $8,615,000 | 2.01% |
| Boxer Capital, LLC | 507,374 | $25,627,000 | 1.62% |
| Rock Springs Capital Management LP | 979,174 | $49,458,000 | 1.44% |
| EFG Asset Management (North America) Corp. | 130,454 | $6,589,000 | 1.39% |
| Integral Health Asset Management, LLC | 130,000 | $6,566,000 | 1.35% |